T1	Gene_or_protein	14 29	tyrosine kinase
T2	Chemical	14 40	tyrosine kinase inhibitors
T3	Chemical	43 47	TKIs
T4	Chemical	50 59	gefitinib
T5	Chemical	64 77	erlotinib are
T6	Disease	91 134	non-small cell lung cancers ( NSCLCs ) with
T7	Limited_variation	135 193	epidermal growth factor receptor ( EGFR ) gene mutations .
R1	treats	Arg1:T1	Arg2:T6
R2	decreases	Arg1:T2	Arg2:T1
R3	treats	Arg1:T2	Arg2:T6
R4	isEquivalentTo	Arg1:T3	Arg2:T1
R5	isEquivalentTo	Arg1:T3	Arg2:T2
R6	treats	Arg1:T3	Arg2:T6
R7	treats	Arg1:T4	Arg2:T6
R8	treats	Arg1:T5	Arg2:T6
R9	isAssociatedWith	Arg1:T6	Arg2:T1
R10	isAssociatedWith	Arg1:T6	Arg2:T2
R11	isAssociatedWith	Arg1:T6	Arg2:T3
R12	isAssociatedWith	Arg1:T6	Arg2:T4
R13	isAssociatedWith	Arg1:T6	Arg2:T5
R14	isAssociatedWith	Arg1:T6	Arg2:T7
R15	isAssociatedWith	Arg1:T7	Arg2:T1
R16	isAssociatedWith	Arg1:T7	Arg2:T2
R17	isAssociatedWith	Arg1:T7	Arg2:T3
R18	isAssociatedWith	Arg1:T7	Arg2:T4
R19	isAssociatedWith	Arg1:T7	Arg2:T5
R20	isAssociatedWith	Arg1:T7	Arg2:T6
